Top Markets
Coin of the day
In Veritas Medical Diagnostics, Inc. In Veritas Medical Diagnostics, Inc.

In Veritas Medical Diagnostics, Inc.

IVME
株式のランク #41113
In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its... In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its development phase, dedicated to researching and creating advanced medical devices for point-of-care diagnostics. Their leading product is a prothrombin monitor, which assesses blood coagulation in patients at risk of cardiovascular diseases and strokes. The company is also actively developing an array of other diagnostic tools. These include a consumer-oriented device to predict the onset of labor for maternity planning, a comprehensive biomarker monitor capable of identifying indicators for conditions such as heart attacks, HIV, cholesterol levels, and cancer. Further innovations under development feature a non-invasive device for continuous blood glucose concentration measurement, a digital scanning machine designed as a non-invasive alternative to traditional 2D X-rays, and an osteoporosis device providing instant bone mineral density readings for patients. Additionally, they are working on a portable digital strip reader for immunoassay applications. Formerly known as In Vivo Medical Diagnostics, Inc., the company officially adopted its current name in 2005. Its operations are headquartered in Inverness, United Kingdom.
株価
$0.0007
最終同期: 2025-09-02
時価総額
$42.26K
変化(1日)
0.00%
変化(1年)
0.00%
GB
取引 In Veritas Medical Diagnostics, Inc. (IVME)

カテゴリー

In Veritas Medical Diagnostics, Inc.(IVME)のP/B比率
2026 時点のP/B比率 TTM: 0
In Veritas Medical Diagnostics, Inc. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0 です。2026 年末時点でのP/B比率は 0 でした。
In Veritas Medical Diagnostics, Inc. の P/B 比率の履歴(2026 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
提供された日付のデータは十分ではありません。